136 related articles for article (PubMed ID: 38536477)
21. Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.
Osswald M; Blaes J; Liao Y; Solecki G; Gömmel M; Berghoff AS; Salphati L; Wallin JJ; Phillips HS; Wick W; Winkler F
Clin Cancer Res; 2016 Dec; 22(24):6078-6087. PubMed ID: 27521448
[TBL] [Abstract][Full Text] [Related]
22. SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases.
Khan M; Lin J; Liao G; Tian Y; Liang Y; Li R; Liu M; Yuan Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818798792. PubMed ID: 30213236
[TBL] [Abstract][Full Text] [Related]
23. A pathology-based substrate for target definition in radiosurgery of brain metastases.
Baumert BG; Rutten I; Dehing-Oberije C; Twijnstra A; Dirx MJ; Debougnoux-Huppertz RM; Lambin P; Kubat B
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):187-94. PubMed ID: 16814946
[TBL] [Abstract][Full Text] [Related]
24. [Immunotherapy for patients with malignant melanoma and brain metastases].
Simonsen LT; Schmidt AMS; Øllegaard TH; Svane IM; Bastholt L; Luczak AA; Schmidt H
Ugeskr Laeger; 2019 Jun; 181(24):. PubMed ID: 31267950
[TBL] [Abstract][Full Text] [Related]
25. Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.
Jones PS; Cahill DP; Brastianos PK; Flaherty KT; Curry WT
Neurosurg Focus; 2015 Mar; 38(3):E5. PubMed ID: 25727227
[TBL] [Abstract][Full Text] [Related]
26. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.
Powell JW; Chung CT; Shah HR; Canute GW; Hodge CJ; Bassano DA; Liu L; Mitchell L; Hahn SS
J Neurosurg; 2008 Dec; 109 Suppl():122-8. PubMed ID: 19123898
[TBL] [Abstract][Full Text] [Related]
27. The biology of melanoma brain metastasis.
Fidler IJ; Schackert G; Zhang RD; Radinsky R; Fujimaki T
Cancer Metastasis Rev; 1999; 18(3):387-400. PubMed ID: 10721492
[TBL] [Abstract][Full Text] [Related]
28. Melanoma Brain Metastases in the Era of Target Therapies: An Overview.
Becco P; Gallo S; Poletto S; Frascione MPM; Crotto L; Zaccagna A; Paruzzo L; Caravelli D; Carnevale-Schianca F; Aglietta M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575838
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy as a Turning Point in the Treatment of Melanoma Brain Metastases.
Fernandes GNC
Discoveries (Craiova); 2023; 11(2):e169. PubMed ID: 37583899
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory Drugs in Melanoma Brain Metastases.
Fernandes GNC
Discoveries (Craiova); 2019 Jun; 7(2):e93. PubMed ID: 32309611
[TBL] [Abstract][Full Text] [Related]
31. Nasal administration of recombinant
Battistoni A; Lantier L; di Tommaso A; Ducournau C; Lajoie L; Samimi M; Coënon L; Rivière C; Epardaud M; Hertereau L; Poupée-Beaugé A; Rieu J; Mévélec MN; Lee GS; Moiré N; Germon S; Dimier-Poisson I
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37192784
[TBL] [Abstract][Full Text] [Related]
32. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells.
Aboody KS; Najbauer J; Schmidt NO; Yang W; Wu JK; Zhuge Y; Przylecki W; Carroll R; Black PM; Perides G
Neuro Oncol; 2006 Apr; 8(2):119-26. PubMed ID: 16524944
[TBL] [Abstract][Full Text] [Related]
33. Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.
Hwu WJ; Lis E; Menell JH; Panageas KS; Lamb LA; Merrell J; Williams LJ; Krown SE; Chapman PB; Livingston PO; Wolchok JD; Houghton AN
Cancer; 2005 Jun; 103(12):2590-7. PubMed ID: 15861414
[TBL] [Abstract][Full Text] [Related]
34. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
Murrell J; Board R
Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
[TBL] [Abstract][Full Text] [Related]
35. Melanoma brain metastases in Ireland: surgical and systemic considerations.
O'Halloran PJ; Cleary A; Cryan JB; Beausang A; Brett FM; Caird J
Br J Neurosurg; 2022 Apr; 36(2):236-240. PubMed ID: 33904364
[TBL] [Abstract][Full Text] [Related]
36. Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma.
Váraljai R; Horn S; Sucker A; Piercianek D; Schmitt V; Carpinteiro A; Becker KA; Reifenberger J; Roesch A; Felsberg J; Reifenberger G; Sure U; Schadendorf D; Helfrich I
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578810
[TBL] [Abstract][Full Text] [Related]
37. First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma.
Wang X; Haaland B; Hu-Lieskovan S; Colman H; Holmen SL
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1419. PubMed ID: 34137219
[TBL] [Abstract][Full Text] [Related]
38. Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA.
Kessel KA; Deichl A; Gempt J; Meyer B; Posch C; Diehl C; Zimmer C; Combs SE
Clin Transl Oncol; 2021 Oct; 23(10):2020-2029. PubMed ID: 33993415
[TBL] [Abstract][Full Text] [Related]
39. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases.
Ahmed KA; Freilich JM; Sloot S; Figura N; Gibney GT; Weber JS; Sarangkasiri S; Chinnaiyan P; Forsyth PA; Etame AB; Rao NG
J Neurooncol; 2015 Mar; 122(1):121-6. PubMed ID: 25519302
[TBL] [Abstract][Full Text] [Related]
40. Brain metastases in children with melanoma.
Rodriguez-Galindo C; Pappo AS; Kaste SC; Rao BN; Cain A; Jenkins JJ; Kun LE; Pratt CB
Cancer; 1997 Jun; 79(12):2440-5. PubMed ID: 9191536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
